The United States is caught in an epidemic of prescription drug overuse and abuse, and efforts to counter such activity are affecting drug distribution, prescribing, and oversight. Just as troubling is the appearance of counterfeit versions of critical drugs, and continued shortages of vital medications have generated interest in new approaches to ensure that the drug supply chain can reliably deliver safe and effective therapies.
↧